Organon

Roivant’s magic trick: Finding the ‘weird-shaped’ pieces around Big Pharma’s cookie cutters
Pharma Voice
Thu, 09/26/24 - 11:00 am
Roivant
Dermavant
Organon
M&A
Big Pharma
Matt Gline
Organon pays up to $1.2B to acquire Dermavant and its steroid-free skin cream Vtama
Fierce Pharma
Wed, 09/18/24 - 01:39 pm
Organon
Roivant
Dermavant
M&A
immuno-dermatology
After Europe deal, Organon pays $22.5M to expand Emgality marketing pact with Lilly
Fierce Pharma
Tue, 08/20/24 - 11:34 am
Organon
Europe
Eli Lilly
Emgality
Rayvow
migraines
Organon’s Commitment to Addressing Contraceptive Deserts
Xtalks
Thu, 03/7/24 - 11:15 am
Organon
contraceptives
Women's Health
contraceptive deserts
Organon's prolific asthma med Singulair needs new safety labeling, NY attorney general argues
Fierce Pharma
Tue, 02/27/24 - 11:26 am
Organon
Singulair
New York
side effects
After migraine accord with Eli Lilly, Organon CEO scouts more deals to bolster growth
Fierce Pharma
Fri, 02/16/24 - 11:45 am
Organon
Eli Lilly
Emgality
Organon pays $50M to pick up rights to pair of Eli Lilly migraine meds in Europe
Fierce Pharma
Mon, 12/18/23 - 10:16 pm
Organon
Eli Lilly
migraines
Europe
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
Dermatology Times
Wed, 11/8/23 - 09:55 pm
Samsung Bioepis
Organon
FDA
AbbVie
Humira
biosimilars
For women’s health, Organon changed the financial language
Pharma Voice
Wed, 10/18/23 - 10:11 am
Organon
Women's Health
R&D
sustainable financing
Organon publishes post-market study of JADA PPH control system
Clinical Trials Arena
Fri, 09/15/23 - 11:45 am
Organon
post-marketing studies
JADA
postpartum hemorrhage
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
Thu, 07/27/23 - 10:25 am
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
7 companies are rolling out Humira biosimilars
Drugstore News
Wed, 07/12/23 - 09:44 am
AbbVie
Humira
biosimilars
Boehringer Ingelheim
Organon
Samsung Bioepsis
Sandoz
Fresenius Kabi
Celltrion
Coherus Biosciences
Biocon
Study: Biosimilars ‘fulfilling their promise’ of lowering biologic prices
BioSpace
Wed, 06/7/23 - 11:22 am
biosimilars
biologics
drug pricing
Roche
Herceptin
Amgen
Kanjinti
Viatris
Ogivri
Pfizer
Trazimera
Teva Pharmaceutical
Herzuma
Organon
Ontruzant
Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'
Fierce Biotech
Thu, 03/16/23 - 09:09 pm
Organon
Women's Health
endometriosis
Organon doubles down on mission to prevent unplanned pregnancies with $30M investment
Endpoints
Wed, 03/8/23 - 09:50 pm
Organon
reproductive health
Organon CEO pins high hopes on upcoming Humira biosimilar launch
Fierce Pharma
Thu, 02/17/22 - 11:18 pm
Organon
biosimilar
Humira
drug launches
AbbVie
Organon gives staff the day off for International Women's Day to focus on their health
Fierce Pharma
Wed, 02/2/22 - 11:07 am
Organon
Merck
Women's Health
employee satisfaction
employees
Spinoff updates: Merck’s Organon and Novartis’ Sandoz
Generics and Biosimilar Initiative
Mon, 11/29/21 - 11:08 pm
spinoffs
Merck
Organon
earnings
Novartis
Sandoz
biosimilars
Organon makes another women’s health move with deal for endometriosis-focused Forendo
MedCity News
Thu, 11/11/21 - 10:58 am
Organon
Forendo Pharma
Merck
endometriosis
M&A
Women's Health
Merck women's health spinoff Organon debuts first awareness campaign, taking on unplanned pregnancy
Fierce Pharma
Tue, 09/21/21 - 10:53 pm
Organon
Merck
spinoffs
Women's Health

Pages